Loading resource…

Heart Failure Association of the European Society of Cardiology
This position paper, published in the European Journal of Heart Failure, addresses the complex interplay between guideline-directed medical therapies (GDMT) for heart failure and renal function. It synthesizes current evidence on how various GDMTs, including SGLT2 inhibitors, affect kidney outcomes in heart failure patients. The document aims to provide a consensus perspective on these interactions, highlighting both benefits and potential concerns for renal health in this population.
No account needed